The Swiss-based biopharmaceutical company designs, discovers and develops therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins.

Diseases it is targeting with these products include Alzheimer's, Parkinson’s, Down syndrome and glaucoma.